These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 11797767)
41. Vaccines in development against West Nile virus. Brandler S; Tangy F Viruses; 2013 Sep; 5(10):2384-409. PubMed ID: 24084235 [TBL] [Abstract][Full Text] [Related]
42. The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys. Muraki Y; Fujita T; Matsuura M; Fuke I; Manabe S; Ishikawa T; Okuno Y; Morita K Virol J; 2015 Apr; 12():54. PubMed ID: 25889682 [TBL] [Abstract][Full Text] [Related]
43. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses. Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007 [TBL] [Abstract][Full Text] [Related]
44. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Monath TP; McCarthy K; Bedford P; Johnson CT; Nichols R; Yoksan S; Marchesani R; Knauber M; Wells KH; Arroyo J; Guirakhoo F Vaccine; 2002 Jan; 20(7-8):1004-18. PubMed ID: 11803060 [TBL] [Abstract][Full Text] [Related]
45. Japanese encephalitis vaccines: current vaccines and future prospects. Monath TP Curr Top Microbiol Immunol; 2002; 267():105-38. PubMed ID: 12082985 [TBL] [Abstract][Full Text] [Related]
46. Immunological response in horses following West Nile virus vaccination with inactivated or recombinant vaccine. Monaco F; Purpari G; Di Gennaro A; Mira F; Di Marco P; Guercio A; Savini G Vet Ital; 2019 Mar; 55(1):73-79. PubMed ID: 30951184 [TBL] [Abstract][Full Text] [Related]
47. Vaccines Against Dengue and West Nile Viruses in India: The Need of the Hour. Gore MM Viral Immunol; 2020; 33(6):423-433. PubMed ID: 32320353 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses. Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448 [TBL] [Abstract][Full Text] [Related]
49. Use of live and inactivated vaccines in the control of West Nile fever in domestic geese. Malkinson M; Banet C; Khinich Y; Samina I; Pokamunski S; Weisman Y Ann N Y Acad Sci; 2001 Dec; 951():255-61. PubMed ID: 11797782 [TBL] [Abstract][Full Text] [Related]
50. DNA vaccines encoding the envelope protein of West Nile virus lineages 1 or 2 administered intramuscularly, via electroporation and with recombinant virus protein induce partial protection in large falcons (Falco spp.). Fischer D; Angenvoort J; Ziegler U; Fast C; Maier K; Chabierski S; Eiden M; Ulbert S; Groschup MH; Lierz M Vet Res; 2015 Aug; 46(1):87. PubMed ID: 26282836 [TBL] [Abstract][Full Text] [Related]
51. Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors. Hanley KA; Goddard LB; Gilmore LE; Scott TW; Speicher J; Murphy BR; Pletnev AG Vector Borne Zoonotic Dis; 2005; 5(1):1-10. PubMed ID: 15815144 [TBL] [Abstract][Full Text] [Related]
53. Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥ 50 years of age. Dayan GH; Bevilacqua J; Coleman D; Buldo A; Risi G Vaccine; 2012 Oct; 30(47):6656-64. PubMed ID: 22959989 [TBL] [Abstract][Full Text] [Related]
54. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine. Lim CK; Takasaki T; Kotaki A; Kurane I Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions. Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384 [TBL] [Abstract][Full Text] [Related]
56. Serologic response to West Nile virus vaccination in the greater one-horned rhinoceros (Rhinoceros unicornis). Wolf TM; Gandolf AR; Dooley JL; Atkinson MW; Wolfe BA J Zoo Wildl Med; 2008 Dec; 39(4):537-41. PubMed ID: 19110693 [TBL] [Abstract][Full Text] [Related]
57. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII. Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075 [TBL] [Abstract][Full Text] [Related]
58. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus. Huang CY; Silengo SJ; Whiteman MC; Kinney RM J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884 [TBL] [Abstract][Full Text] [Related]
60. Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus. Beasley DW Immunotherapy; 2011 Feb; 3(2):269-85. PubMed ID: 21322763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]